Entity
Description
  • Value proposition

    PepKon is a French biotech founded in 2022, built on more than a decade of academic research.
    The company develops first-in-class peptide therapeutics for incurable cancers.

  • PepKon - first-in-class peptides in oncology, inspired by human biology

    Pepkon is a biotech company developing a therapeutic peptide platform in oncology. Its lead candidate is an agonist peptide targeting the TSP-1/CD47 pathway.

  • https://www.pepkon.fr/
  • Website is possibly disabled or domain is for sale
Catalyst interactions
Catalyst Type Tweets Articles
Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations (Auto)
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations (Auto)
Other

5 Jul 2023


La French Tech
La French Tech
Media, Public Policy Offices (Auto)
La French Tech
Media, Public Policy Offices (Auto)
Other

22 Jun 2023


Agoranov
Agoranov
Startup accelerator & VC, Technology, Information and Internet (Auto)
Agoranov
Startup accelerator & VC, Technology, Information and Internet (Auto)
Other

13 Mar 2024


Social network dynamics
Loading...